Ignite Creation Date:
2025-12-18 @ 8:36 AM
Ignite Modification Date:
2025-12-23 @ 9:49 PM
Study NCT ID:
NCT03246685
Status:
None
Last Update Posted:
2018-12-14 00:00:00
First Post:
2017-07-22 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-22 00:00:00
First Submit QC Date:
None
Study First Post Date:
2017-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-12 00:00:00
Last Update Post Date:
2018-12-14 00:00:00
Last Update Post Date Type:
ACTUAL